- Home
- QUAD vs MGTX Comparison
QUAD vs MGTX Comparison
Compare QUAD & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUAD
- MGTX
- Stock Information
- Founded
- QUAD 1971
- MGTX 2015
- Country
- QUAD United States
- MGTX United States
- Employees
- QUAD N/A
- MGTX N/A
- Industry
- QUAD Publishing
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QUAD Consumer Discretionary
- MGTX Health Care
- Exchange
- QUAD Nasdaq
- MGTX Nasdaq
- Market Cap
- QUAD 408.6M
- MGTX 479.9M
- IPO Year
- QUAD 2010
- MGTX N/A
- Fundamental
- Price
- QUAD $6.00
- MGTX $7.30
- Analyst Decision
- QUAD Strong Buy
- MGTX Strong Buy
- Analyst Count
- QUAD 2
- MGTX 2
- Target Price
- QUAD $10.15
- MGTX $23.50
- AVG Volume (30 Days)
- QUAD 335.2K
- MGTX 278.8K
- Earning Date
- QUAD 02-18-2025
- MGTX 03-13-2025
- Dividend Yield
- QUAD 3.76%
- MGTX N/A
- EPS Growth
- QUAD N/A
- MGTX N/A
- EPS
- QUAD N/A
- MGTX N/A
- Revenue
- QUAD $2,672,200,000.00
- MGTX $13,929,000.00
- Revenue This Year
- QUAD N/A
- MGTX N/A
- Revenue Next Year
- QUAD N/A
- MGTX $1,391.84
- P/E Ratio
- QUAD N/A
- MGTX N/A
- Revenue Growth
- QUAD N/A
- MGTX 108.24
- 52 Week Low
- QUAD $4.06
- MGTX $3.85
- 52 Week High
- QUAD $9.13
- MGTX $7.80
- Technical
- Relative Strength Index (RSI)
- QUAD 40.04
- MGTX 66.58
- Support Level
- QUAD $6.57
- MGTX $6.72
- Resistance Level
- QUAD $8.04
- MGTX $7.06
- Average True Range (ATR)
- QUAD 0.64
- MGTX 0.37
- MACD
- QUAD -0.06
- MGTX 0.05
- Stochastic Oscillator
- QUAD 1.92
- MGTX 71.61
About QUAD Quad Graphics Inc
Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.